knowledge -WSS

knowledge

author：entertainment 2025-09-14 10:02:19 - browse：21

intarcia implant. -- health tech coverage from STAT — The matchstick-sized, implantable device from Intarcia Therapeutics releases a steady, continuous, and low-dose stream of a drug for diabetes. Stuart Isett/Fortune Brainstorm Health

An advisory panel to the Food and Drug Administration unanimously voted against a diabetes implant from Intarcia Therapeutics — a former biotech unicorn that faltered after the FDA rejected said implant not once, but twice.

Intarcia called for the panel meeting because of those two rejections, seeking outside input on the FDA’s decision. FDA then granted Intarcia’s request. The agency is not bound to advisory panel decisions, though it tends to follow their advice.

Intarcia started developing its lead therapy, a small, skinny bar implanted under the skin, for type 2 diabetes patients in 2016. The implant delivers a glucose-controlling medicine called exenatide, a member of the GLP-1 drugs that have taken the diabetes and obesity markets by storm. Intarcia’s implant continuously administers the drug over six months, with the goal of improving patient adherence compared to Eli Lilly and Novo Nordisk’s weekly GLP-1 shots.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

knowledge

WSS

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

White House announces new plan to address the growing threat of xylazine in overdose crisis

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

Teachers share how revamped forgiveness program helped with their student loans

The U.S. needs a new definition of substance use “recovery”

Teachers share how revamped forgiveness program helped with their student loans

explore

knowledge

leisure time

Hepatitis C has a cure — but many Americans still lack access to it

Biden’s NIH nominee is languishing in Congress

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Recent heat wave in the Mediterranean caused by climate change: Study

Peter Hotez and the public health issue of online harassment

Pandemic and All Hazards Preparedness Act needs lean update

Supreme Court strikes down use of affirmative action

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The aspartame in Diet Coke probably isn’t giving you cancer

hotspot

Retired US general questions alleged Putin, Prigozhin meeting

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Swim instructor mom warns parents not to buy blue swimsuits for kids

Create a giant ice tray with this foil pan hack to keep food cold this summer

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Eisai exec who led development of Alzheimer’s drug to retire

entertainment

explore

knowledge

explore